“Uro-Oncology Tumor board: Challenges of Prostate Cancer Treatment” (Semi-Virtual)

November 16, 2021

Author: Acteropharma

Uro-Oncology research Center of Tehran University of Medical science, in cooperation with Actero Pharma has held a semi-virtual tumor board “Challenges of Prostate Cancer Treatment”, where the newest data of prostate cancer treatment has been shared, which were followed by some real case presentation. We are honored to have such a terrific collaboration with the most scientific centers in Iran in order to make sure our patient’s will go through the best options in their treatment journey.

Last News

Actero Support in Congress 1400

Site
July 24, 2022

Author:

Acteropharma
Actero company’s social respomsibility of patient support in Hematology-Oncology Congress and Radiation Therapy Congress

Best of ASCO 2021

Dr-noroozi-event-2048x1367
November 16, 2021

Author:

Acteropharma
The aforesaid seminar has been held for the first time in Iran with the hospitality of Isfahan city, with the cooperation of Radiation-Oncologists from all over of the country and Actero Pharma.

“Uro-Oncology Tumor board: Challenges of Prostate Cancer Treatment” (Semi-Virtual)

Dr-noroozi-event-2048x1367
November 16, 2021

Author:

Acteropharma
Uro-Oncology research Center of Tehran University of Medical science, in cooperation with Actero Pharma has held a semi-virtual tumor board.